Cargando…

PB2691: ARSENIC RETENTION IN TISSUES AND QUALITY OF LIFE IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ARSENICALS: A CROSS SECTIONAL STUDY

Detalles Bibliográficos
Autores principales:	Wu, Chao, Xue, Changwen, Zhang, LI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428850/ http://dx.doi.org/10.1097/01.HS9.0000977436.44107.bb

Ejemplares similares

PB1827: ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
por: Marques, I., et al.
Publicado: (2022)

PB1891: EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
por: Koubaa, Asma, et al.
Publicado: (2023)

PB1901: NOT ALL VARIANTS OF ACUTE PROMYELOCYTIC LEUKEMIAS ARE RESISTANT TO RETINOIDS.
por: Dandwani, Mehndi, et al.
Publicado: (2023)

PB1819: CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
por: kasser, O., et al.
Publicado: (2022)

PB1895: CHARACTERISTICS AND OUTCOME OF PEADIATRIC ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
por: Koubaa, Asma, et al.
Publicado: (2023)

PB1816: CHEMOTHERAPY FREE APPROACH IN A PEDIATRIC PATIENT WITH VERY LATE CUTANEOUS RELAPSE OF ACUTE PROMYELOCYTIC LEUKEMIA.
por: Crisci, V., et al.
Publicado: (2022)

PB1803: EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA: DEFINING HIGH RISK PATIENTS
por: `Ben Salah, M., et al.
Publicado: (2022)

PB1802: ACUTE PROMYELOCYTIC LEUKEMIA AND THROMBOSIS: HOW TO IDENTIFY THE HIGH-RISK PATIENTS?
por: `Ben Salah, M., et al.
Publicado: (2022)

PB2227: TRANSFORMATION OF MYELOPROLIFERATIVE NEOPLASMS INTO ACUTE PROMYELOCYTIC LEUKEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS
por: Găman, Mihnea-Alexandru
Publicado: (2023)

Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005)

Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012)

PB1851: EARLY DEATHS IN PATIENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE STUDY FROM A GENERAL HOSPITAL
por: Yohannan, B., et al.
Publicado: (2022)

PB1786: TRINARY FUSION AND LIGAND BINDING DOMAIN TRUNCATION AS RECURRENT AND CRUCIAL MOLECULAR CHARACTERISTICS IN RARG-DRIVEN ACUTE PROMYELOCYTIC LEUKEMIA AND RENDER UNRESPONSIVE TO ALL-TRANS RETINOIC ACID
por: Zhou, Xiaosu, et al.
Publicado: (2023)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

PB2594: BACTEREMIA AND FEBRILE NEUTROPENIA IN PATIENTS TREATED FOR ACUTE LEUKEMIA
por: Inaam, Bizid, et al.
Publicado: (2023)

PB1799: KMT2A-REARRANGED PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Zerkalenkova, E., et al.
Publicado: (2022)

PB1745: SURVIVAL AND PROGNOSTIC FACTORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA IN OMAN.
por: Almamari, Moza, et al.
Publicado: (2023)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

PB1759: TWENTY-ONE YEARS’ EXPERIENCE OF ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC PROTOCOL: MONOCENTRIC STUDY
por: Frikha, I., et al.
Publicado: (2022)

PB1883: IMPLANTATION AND LONG-TERM USE OF PERIPHERALLY-INSERTED CENTRAL CATHETER ARE SAFE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKAEMIA
por: Szotkowski, Tomáš, et al.
Publicado: (2023)

PB1775: TRANSPOSABLE ELEMENT PARTICIPATES IN COMPOSING STAT3::RARA::LTR40A-RC TRINARY FUSION IN VARIANT ACUTE PROMYELOCYTIC LEUKEMIA AND CONFERS ATRA RESISTANCE VIA LIGAND BINDING DOMAIN TRUNCATION
por: Chen, Xue, et al.
Publicado: (2023)

PB1751: ALTERATIONS IN THE GUT MICROBIOME IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT PATIENTS WITH ACUTE LEUKEMIA
por: Park, M., et al.
Publicado: (2022)

PB1828: REALGAR (AS4S4), A TRADITIONAL CHINESE MEDICINE, INDUCES ACUTE PROMYELOCYTIC LEUKEMIA CELL DEATH VIA THE BCL-2/BAX/CYT-C/AIF SIGNALING PATHWAY IN VITRO
por: LI, Zonghong, et al.
Publicado: (2023)

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy
por: Efficace, Fabio, et al.
Publicado: (2021)

PB1822: A CASE OF EXTRAMEDULLARY ACUTE MYELOID LEUKEMIA SUCCESSFULLY TREATED WITH NOVEL AGENTS
por: Gianfelici, V., et al.
Publicado: (2022)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
por: Zheng, Yu, et al.
Publicado: (2021)

PB1812: CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA IN PEDIATRIC POPULATION: THE RESULTS OF A MONOCENTRIC EXPERIENCE
por: Charfi, H., et al.
Publicado: (2022)

Dexamethasone suppresses long QT phenotype in patient with acute promyelocytic leukemia treated with arsenic
por: Winterfield, Jeffrey R., et al.
Publicado: (2015)

Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia
por: Epstein-Peterson, Zachary D., et al.
Publicado: (2022)

PB1812: CO-MUTATION PROFILE IN A REAL-LIFE COHORT OF ACUTE MYELOID LEUKEMIA (AML)
por: Piras, Giovanna, et al.
Publicado: (2023)

PB1861: EFFICACY AND TOXICITY OF VENETOCLAX PLUS HYPOMETHYLATING AGENTS IN THE REAL LIFE OF ACUTE MYELOID LEUKEMIA
por: Martini, Gianluca, et al.
Publicado: (2023)

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
por: Ma, Ya-Fang, et al.
Publicado: (2022)

PB1724: NILOTINIB PLUS CHEMOTHERAPY IN PEDIATRICS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LEUKEMIA: A SINGLE CENTER EXPERIENCE
por: LI, Yanming, et al.
Publicado: (2023)

PB1813: REGULATORY MECHANISMS AND THERAPEUTIC POTENTIAL OF THE DLK1-DIO3 LOCUS IN PEDIATRIC ACUTE MEGAKARYOBLASTIC LEUKEMIA
por: Verboon, Lonneke, et al.
Publicado: (2023)

PB1809: CLINICAL TRAJECTORY OF LONG-TERM SURVIVORS OF ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE INDUCTION CHEMOTHERAPY
por: Heering, G., et al.
Publicado: (2022)

PB1839: CYTOGENETIC PROFILE OF ACUTE MYELOBLASTIC LEUKEMIA TREATED AT THE MOHAMMED V MILITARY HOSPITAL IN RABAT (MOROCCO).
por: Hawa, Moussa Bouh, et al.
Publicado: (2023)

PB2414: TOTAL BODY IRRADIATION VERSUS NON TOTAL BODY IRRADIATION CONTAINING REGIMENS FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
por: Mekni, Sabrine, et al.
Publicado: (2023)

PB1735: ONLINE CME PROGRAM IMPROVED CLINICIANS’ ABILITY TO MANAGE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH ASPARAGINASE-BASED THERAPIES
por: Bomba, Sarah Elizabeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ea59m4jr155ngd9mfg19r07mr